Abstract
Objective To study the value of serum soluble intercellular adhesion molecule-1 (sICAM-1),B-type natriuretic peptide (BNP) and C-reactive protein (CRP) levels detection on assessment of illness in patients with congestive heart failure.Methods Sixty-three patients with congestive heart failure were involved in this study.The levels of serum sICAM-1,BNP and CRP were compared in patients with different NYHA cardiac function classification before and after treatment.Results The levels of serum sICAM-1,BNP and CRP in NYHA cardiac function classification ≥ Ⅲ grade patients were significantly higher than those in NYHA cardiac function classification ＜ Ⅲ grade patients [ (392.6 ± 73.3) μ g/L vs.(212.6 ± 83.4) μ g/L,( 1992.5 ±1173.7) ng/L vs.(512.6 ± 283.2) ng/L,(49.3 ± 33.5 ) mg/L vs.(6.1 ± 3.6) mg/L] (P ＜ 0.01 ).The levels of serum sICAM-1,BNP and CRP after treatment were significantly decreased compared with those before treatment [ ( 168.9 ± 52.5) μ g/L vs.(362.8 ± 123.1 ) μ g/L,(68.6 ± 38.4) ng/L vs.(1470.9± 1460.1) ng/L,(3.6±2.8) mg/L vs.(34.1 ±29.8) mg/L] (P ＜ 0.01).Conclusion Serum sICAM-1,BNP and CRP levels are positively related with illness,and serum sICAM-1,BNP and CRP levels may be judged as an index assessing treatment effect and prognosis. Key words: Heart failure, congestive; Natriuretic peptide, brain; C-reactive protein; Intercellular adhesion molecule-1
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
